These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 16856875)

  • 21. Soluble CD40L, platelet surface CD40L and total platelet CD40L in congestive heart failure: relationship to platelet volume, mass and granularity.
    Chung I; Choudhury A; Patel J; Lip GY
    J Intern Med; 2008 Mar; 263(3):313-21. PubMed ID: 18086125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria.
    Ferroni P; Guagnano MT; Falco A; Paoletti V; Manigrasso MR; Michetti N; Santilli F; Guadagni F; Basili S; Davì G
    Clin Sci (Lond); 2008 Mar; 114(6):449-55. PubMed ID: 17988217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adiponectin diminishes platelet aggregation and sCD40L release. Potential role in the metabolic syndrome.
    Restituto P; Colina I; Varo JJ; Varo N
    Am J Physiol Endocrinol Metab; 2010 May; 298(5):E1072-7. PubMed ID: 20197504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of blood sampling procedure on plasma concentrations of matrix metalloproteinases and their tissue inhibitors.
    Rossignol P; Cambillau M; Bissery A; Mouradian D; Benetos A; Michel JB; Plouin PF; Chatellier G; Jacob MP
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):464-9. PubMed ID: 18307742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble CD40L levels are regulated by the -3459 A>G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome.
    Mälarstig A; Lindahl B; Wallentin L; Siegbahn A
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1667-73. PubMed ID: 16627810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
    Tan KT; Tayebjee MH; Lim HS; Lip GY
    Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of serum soluble CD40 ligand (sCD40L) in the patients undergoing allogeneic stem cell transplantation: platelet is a major source of serum sCD40L.
    Nagasawa M; Zhu Y; Isoda T; Tomizawa D; Itoh S; Kajiwara M; Morio T; Nonoyama S; Shimizu N; Mizutani S
    Eur J Haematol; 2005 Jan; 74(1):54-60. PubMed ID: 15613107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of elevated serum soluble CD40 ligand on the prognostic value in patients with acute coronary syndromes.
    Yan JC; Zhu J; Gao L; Wu ZG; Kong XT; Zong RQ; Zhan LZ
    Clin Chim Acta; 2004 May; 343(1-2):155-9. PubMed ID: 15115688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study.
    de Lemos JA; Zirlik A; Schönbeck U; Varo N; Murphy SA; Khera A; McGuire DK; Stanek G; Lo HS; Nuzzo R; Morrow DA; Peshock R; Libby P
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2192-6. PubMed ID: 16109925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Changes and relations of soluble plasma CD40L and matrix metalloproteinase-9 levels in patients with coronary heart disease].
    Li J; Zhao SP; Peng DQ; Zhou HN
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):517-20. PubMed ID: 16137036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble CD40 ligand as a biomarker for storage-related preanalytic variations of human serum.
    Lengellé J; Panopoulos E; Betsou F
    Cytokine; 2008 Nov; 44(2):275-82. PubMed ID: 18851919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease.
    Lim PS; Wu MY; Chien SW; Wu TK; Liu CS; Hu CY; Chang HC; Pai MA
    Nephrology (Carlton); 2008 Dec; 13(8):677-83. PubMed ID: 19019166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated circulating CD40L concentrations in patients with systemic sclerosis.
    Komura K; Sato S; Hasegawa M; Fujimoto M; Takehara K
    J Rheumatol; 2004 Mar; 31(3):514-9. PubMed ID: 14994397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical implications of increased expression of CD40L in patients with acute coronary syndromes.
    Yan J; Wu Z; Huang Z; Li L; Zhong R; Kong X
    Chin Med J (Engl); 2002 Apr; 115(4):491-3. PubMed ID: 12133281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability and reproducibility of simultaneously detected plasma and serum cytokine levels in asymptomatic subjects.
    Hosnijeh FS; Krop EJ; Portengen L; Rabkin CS; Linseisen J; Vineis P; Vermeulen R
    Biomarkers; 2010 Mar; 15(2):140-8. PubMed ID: 19848603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation.
    Ferro D; Loffredo L; Polimeni L; Fimognari F; Villari P; Pignatelli P; Fuster V; Violi F
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2763-8. PubMed ID: 17901373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention.
    Choudhury A; Chung I; Panja N; Patel J; Lip GYH
    Chest; 2008 Sep; 134(3):574-581. PubMed ID: 18641098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum levels of soluble CD40 ligand at flare and at remission in patients with systemic lupus erythematosus.
    Urquizu-Padilla M; Balada E; Cortés F; Pérez EH; Vilardell-Tarrés M; Ordi-Ros J
    J Rheumatol; 2009 May; 36(5):953-60. PubMed ID: 19332622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells.
    Damås JK; Otterdal K; Yndestad A; Aass H; Solum NO; Frøland SS; Simonsen S; Aukrust P; Andreassen AK
    Circulation; 2004 Aug; 110(8):999-1005. PubMed ID: 15302794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Release of soluble CD40 ligand after platelet activation: studies on the solubilization phase.
    Otterdal K; Pedersen TM; Solum NO
    Thromb Res; 2004; 114(3):167-77. PubMed ID: 15342213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.